60 Degrees Pharmaceuticals (SXTP) Competitors $0.80 -0.26 (-24.53%) Closing price 01/30/2025 04:00 PM EasternExtended Trading$0.78 -0.03 (-3.13%) As of 01/30/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SXTP vs. RDHL, OBSV, CYCN, ORGS, EVAX, ABVC, GLTO, EDSA, NLSP, and EVOKShould you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include RedHill Biopharma (RDHL), ObsEva (OBSV), Cyclerion Therapeutics (CYCN), Orgenesis (ORGS), Evaxion Biotech A/S (EVAX), ABVC BioPharma (ABVC), Galecto (GLTO), Edesa Biotech (EDSA), NLS Pharmaceutics (NLSP), and Evoke Pharma (EVOK). These companies are all part of the "pharmaceutical products" industry. 60 Degrees Pharmaceuticals vs. RedHill Biopharma ObsEva Cyclerion Therapeutics Orgenesis Evaxion Biotech A/S ABVC BioPharma Galecto Edesa Biotech NLS Pharmaceutics Evoke Pharma 60 Degrees Pharmaceuticals (NASDAQ:SXTP) and RedHill Biopharma (NASDAQ:RDHL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, community ranking, institutional ownership, profitability and dividends. Does the MarketBeat Community prefer SXTP or RDHL? RedHill Biopharma received 426 more outperform votes than 60 Degrees Pharmaceuticals when rated by MarketBeat users. Likewise, 67.14% of users gave RedHill Biopharma an outperform vote while only 8.33% of users gave 60 Degrees Pharmaceuticals an outperform vote. CompanyUnderperformOutperform60 Degrees PharmaceuticalsOutperform Votes18.33%Underperform Votes1191.67% RedHill BiopharmaOutperform Votes42767.14% Underperform Votes20932.86% Is SXTP or RDHL more profitable? Company Net Margins Return on Equity Return on Assets 60 Degrees PharmaceuticalsN/A N/A -113.43% RedHill Biopharma N/A N/A N/A Which has preferable valuation and earnings, SXTP or RDHL? RedHill Biopharma has higher revenue and earnings than 60 Degrees Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio60 Degrees Pharmaceuticals$250K7.36-$3.77M-$10.08-0.08RedHill Biopharma$6.53M1.19$23.92MN/AN/A Which has more volatility & risk, SXTP or RDHL? 60 Degrees Pharmaceuticals has a beta of 4.4, suggesting that its share price is 340% more volatile than the S&P 500. Comparatively, RedHill Biopharma has a beta of 3.69, suggesting that its share price is 269% more volatile than the S&P 500. Do institutionals & insiders hold more shares of SXTP or RDHL? 8.0% of 60 Degrees Pharmaceuticals shares are held by institutional investors. Comparatively, 7.2% of RedHill Biopharma shares are held by institutional investors. 10.3% of 60 Degrees Pharmaceuticals shares are held by insiders. Comparatively, 6.8% of RedHill Biopharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media prefer SXTP or RDHL? In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than RedHill Biopharma. MarketBeat recorded 6 mentions for 60 Degrees Pharmaceuticals and 4 mentions for RedHill Biopharma. 60 Degrees Pharmaceuticals' average media sentiment score of 0.55 beat RedHill Biopharma's score of 0.41 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 60 Degrees Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RedHill Biopharma 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer SXTP or RDHL? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 60 Degrees Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00RedHill Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Summary60 Degrees Pharmaceuticals beats RedHill Biopharma on 7 of the 12 factors compared between the two stocks. Get 60 Degrees Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTP vs. The Competition Export to ExcelMetric60 Degrees PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.84M$6.92B$5.61B$9.14BDividend YieldN/A2.95%5.36%3.98%P/E Ratio-0.0810.1189.6917.66Price / Sales7.36351.361,219.4081.09Price / CashN/A65.4844.3437.71Price / Book-0.085.335.134.73Net Income-$3.77M$157.56M$118.85M$225.42M7 Day Performance-10.53%2.05%1.39%0.75%1 Month Performance-37.98%2.62%7.52%3.61%1 Year Performance185.31%9.59%26.67%21.42% 60 Degrees Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTP60 Degrees Pharmaceuticals0.9328 of 5 stars$0.80-24.5%N/A+160.3%$1.84M$250,000.00-0.083Short Interest ↓News CoverageGap DownRDHLRedHill Biopharma0.645 of 5 stars$6.23-3.3%N/A-98.4%$7.97M$6.53M0.00210Short Interest ↑Gap UpOBSVObsEvaN/AN/AN/AN/A$7.94M$20.11M-0.1150Gap UpCYCNCyclerion Therapeutics2.6732 of 5 stars$2.71+1.1%N/A-8.6%$7.34M$1.62M0.0030Gap UpORGSOrgenesisN/A$1.52+3.4%N/AN/A$7.30M$530,000.000.00150News CoverageEVAXEvaxion Biotech A/S2.9226 of 5 stars$6.00-0.5%$55.00+816.7%-91.5%$7.02M$70,000.00-4.1460Short Interest ↓News CoverageGap DownABVCABVC BioPharma1.5322 of 5 stars$0.54+2.9%N/A-64.1%$7.00M$150,000.00-0.6330Short Interest ↓GLTOGalecto3.0874 of 5 stars$5.30-5.8%$10.00+88.9%-69.3%$6.99MN/A-0.2840Gap DownEDSAEdesa Biotech3.6144 of 5 stars$2.01-9.9%$21.00+944.8%-58.3%$6.98MN/A-1.0420Upcoming EarningsShort Interest ↓Gap DownNLSPNLS PharmaceuticsN/A$1.81+1.7%N/A+312.6%$6.91MN/A0.006Short Interest ↓News CoverageEVOKEvoke Pharma0.3169 of 5 stars$4.59+4.1%N/A-41.5%$6.84M$5.18M-0.424Short Interest ↓ Related Companies and Tools Related Companies RDHL Competitors OBSV Competitors CYCN Competitors ORGS Competitors EVAX Competitors ABVC Competitors GLTO Competitors EDSA Competitors NLSP Competitors EVOK Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SXTP) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
